Yersinia Virulence Depends on Mimicry of Host Rho-Family Nucleotide Dissociation Inhibitors

Cell

Volumn 126, Issue 5, 2006, Pages 869-880

  Prehna, Gerd ^a   Ivanov, Maya I ^b   Bliska, James B ^b   Stebbins, C Erec ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; GUANIDINE DERIVATIVE; GUANIDINE NUCLEOTIDE DISSOCIATION INHIBITOR; MUTANT PROTEIN; NUCLEOTIDE; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM MUTANT; CELL CULTURE; CELL DISRUPTION; CRYSTAL STRUCTURE; CYTOSKELETON; DISSOCIATION; ENZYME ACTIVITY; ENZYME INHIBITION; HOST; HUMAN; HUMAN CELL; MICROBIAL ATTENUATION; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; YERSINIA; YERSINIA PSEUDOTUBERCULOSIS; YERSINIOSIS;

EUKARYOTA; YERSINIA; YERSINIA PSEUDOTUBERCULOSIS;

EID: 33748192535     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2006.06.056     Document Type: Article

References (44)

1. Aepfelbacher M. Modulation of Rho GTPases by type III secretion system translocated effectors of Yersinia. Rev. Physiol. Biochem. Pharmacol. 152 (2004) 65-77
2. Aepfelbacher M., Zumbihl R., Ruckdeschel K., Jacobi C.A., Barz C., and Heesemann J. The tranquilizing injection of Yersinia proteins: a pathogen's strategy to resist host defense. Biol. Chem. 380 (1999) 795-802
3. Barz C., Abahji T.N., Trülzsch K., and Heesemann J. The Yersinia Ser/Thr protein kinase YpkA/YopO directly interacts with the small GTPases RhoA and Rac-1. FEBS Lett. 482 (2000) 139-143
4. Black D.S., and Bliska J.B. The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol. Microbiol. 37 (2000) 515-527
5. Buchwald G., Friebel A., Galán J.E., Hardt W.D., Wittinghofer A., and Scheffzek K. Structural basis for the reversible activation of a Rho protein by the bacterial toxin SopE. EMBO J. 21 (2002) 3286-3295
6. CCP4 (Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50 (1994) 760-763
7. Cornelis G.R. Molecular and cell biology aspects of plague. Proc. Natl. Acad. Sci. USA 97 (2000) 8778-8783
8. Cornelis G.R. The Yersinia Ysc-Yop 'type III' weaponry. Nat. Rev. Mol. Cell Biol. 3 (2002) 742-752
9. Cornelis G.R., Boland A., Boyd A.P., Geuijen C., Iriarte M., Neyt C., Sory M.P., and Stainier I. The virulence plasmid of Yersinia, an antihost genome. Microbiol. Mol. Biol. Rev. 62 (1998) 1315-1352
10. Dukuzumuremyi J.M., Rosqvist R., Hallberg B., Åkerström B., Wolf-Watz H., and Schesser K. The Yersinia protein kinase A is a host factor inducible RhoA/Rac-binding virulence factor. J. Biol. Chem. 275 (2000) 35281-35290
11. Dvorsky R., and Ahmadian M.R. Always look on the bright site of Rho: structural implications for a conserved intermolecular interface. EMBO Rep. 5 (2004) 1130-1136
12. Friebel A., and Hardt W.D. Purification and biochemical activity of Salmonella exchange factor SopE. Methods Enzymol. 325 (2000) 82-91
13. Galán J.E., and Collmer A. Type III secretion machines: bacterial devices for protein delivery into host cells. Science 284 (1999) 1322-1328
14. Galimand M., Guiyoule A., Gerbaud G., Rasoamanana B., Chanteau S., Carniel E., and Courvalin P. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N. Engl. J. Med. 337 (1997) 677-680
15. Galyov E.E., Häkansson S., Forsberg A., and Wolf-Watz H. A secreted protein kinase of Yersinia pseudotuberculosis is an indispensable virulence determinant. Nature 361 (1993) 730-732
16. Galyov E.E., Häkansson S., and Wolf-Watz H. Characterization of the operon encoding the YpkA Ser/Thr protein kinase and the YopJ protein of Yersinia pseudotuberculosis. J. Bacteriol. 176 (1994) 4543-4548
17. Grizot S., Faure J., Fieschi F., Vignais P.V., Dagher M.C., and Pebay-Peyroula E. Crystal structure of the Rac1-RhoGDI complex involved in nadph oxidase activation. Biochemistry 40 (2001) 10007-10013
18. Hakansson S., Galyov E.E., Rosqvist R., and Wolf-Watz H. The Yersinia YpkA Ser/Thr kinase is translocated and subsequently targeted to the inner surface of the HeLa cell plasma membrane. Mol. Microbiol. 20 (1996) 593-603
19. Hardt W.D., Chen L.M., Schuebel K.E., Bustelo X.R., and Galán J.E. S. typhimurium encodes an activator of Rho GTPases that induces membrane ruffling and nuclear responses in host cells. Cell 93 (1998) 815-826
20. Henderson D.A. The looming threat of bioterrorism. Science 283 (1999) 1279-1282
21. Huse M., and Kuriyan J. The conformational plasticity of protein kinases. Cell 109 (2002) 275-282
22. Inglesby T.V., Dennis D.T., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., Fine A.D., Friedlander A.M., Hauer J., Koerner J.F., et al. Plague as a biological weapon: medical and public health management. Working group on civilian biodefense. JAMA 283 (2000) 2281-2290
23. Juris S.J., Rudolph A.E., Huddler D., Orth K., and Dixon J.E. A distinctive role for the Yersinia protein kinase: actin binding, kinase activation, and cytoskeleton disruption. Proc. Natl. Acad. Sci. USA 97 (2000) 9431-9436
24. Logsdon L.K., and Mecsas J. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues. Infect. Immun. 71 (2003) 4595-4607
25. Maesaki R., Ihara K., Shimizu T., Kuroda S., Kaibuchi K., and Hakoshima T. The structural basis of Rho effector recognition revealed by the crystal structure of human RhoA complexed with the effector domain of PKN/PRK1. Mol. Cell 4 (1999) 793-803
26. Maesaki R., Shimizu T., Ihara K., Kuroda S., Kaibuchi K., and Hakoshima T. Biochemical and crystallographic characterization of a Rho effector domain of the protein serine/threonine kinase N in a complex with RhoA. J. Struct. Biol. 126 (1999) 166-170
27. McCormick J.B. Epidemiology of emerging/re-emerging antimicrobial-resistant bacterial pathogens. Curr. Opin. Microbiol. 1 (1998) 125-129
28. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53 (1997) 240-255
29. Nejedlik L., Pierfelice T., and Geiser J.R. Actin distribution is disrupted upon expression of Yersinia YopO/YpkA in yeast. Yeast 21 (2004) 759-768
30. Perrakis A., Morris R., and Lamzin V.S. Automated protein model building combined with iterative structure refinement. Nat. Struct. Biol. 6 (1999) 458-463
31. Perry R.D., and Fetherston J.D. Yersinia pestis-etiologic agent of plague. Clin. Microbiol. Rev. 10 (1997) 35-66
32. Potterton E., Briggs P., Turkenburg M., and Dodson E. A graphical user interface to the CCP4 program suite. Acta Crystallogr. D Biol. Crystallogr. 59 (2003) 1131-1137
33. Rudolph M.G., Weise C., Mirold S., Hillenbrand B., Bader B., Wittinghofer A., and Hardt W.D. Biochemical analysis of SopE from Salmonella typhimurium, a highly efficient guanosine nucleotide exchange factor for RhoGTPases. J. Biol. Chem. 274 (1999) 30501-30509
34. Rypniewski W.R., Holden H.M., and Rayment I. Structural consequences of reductive methylation of lysine residues in hen egg white lysozyme: an X-ray analysis at 1.8-A resolution. Biochemistry 32 (1993) 9851-9858
35. Scheffzek K., Stephan I., Jensen O.N., Illenberger D., and Gierschik P. The Rac-RhoGDI complex and the structural basis for the regulation of Rho proteins by RhoGDI. Nat. Struct. Biol. 7 (2000) 122-126
36. Shao F., Merritt P.M., Bao Z., Innes R.W., and Dixon J.E. A Yersinia effector and a Pseudomonas avirulence protein define a family of cysteine proteases functioning in bacterial pathogenesis. Cell 109 (2002) 575-588
37. Simonet M., and Falkow S. Invasin expression in Yersinia pseudotuberculosis. Infect. Immun. 60 (1992) 4414-4417
38. Stebbins C.E., and Galán J.E. Structural mimicry in bacterial virulence. Nature 412 (2001) 701-705
39. Terwilliger T. SOLVE and RESOLVE: automated structure solution, density modification and model building. J. Synchrotron Radiat. 11 (2004) 49-52
40. Trülzsch K., Sporleder T., Igwe E.I., Rüssmann H., and Heesemann J. Contribution of the major secreted Yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model. Infect. Immun. 72 (2004) 5227-5234
41. Viboud G.I., and Bliska J.B. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu. Rev. Microbiol. 59 (2005) 69-89
42. Wei Y., Zhang Y., Derewenda U., Liu X., Minor W., Nakamoto R.K., Somlyo A.V., Somlyo A.P., and Derewenda Z.S. Crystal structure of RhoA-GDP and its functional implications. Nat. Struct. Biol. 4 (1997) 699-703
43. Winn M.D., Isupov M.N., and Murshudov G.N. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr. D Biol. Crystallogr. 57 (2001) 122-133
44. Winn M.D., Murshudov G.N., and Papiz M.Z. Macromolecular TLS refinement in REFMAC at moderate resolutions. Methods Enzymol. 374 (2003) 300-321